Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron up on receiving European patent notification

** Shares of Immuron  IMC.AX  rise as much as 1.2% to
A$0.088, their highest since June 27
    ** After market hours on Thursday, co received https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02539596-3A596834?access_token=83ff96335c2d45a094df02a206a39ff4
 notification of an intent to grant a European patent for the
compositions and methods for co's treatment of a large intestine
disease caused by toxins produced by the bacterium
Clostridioides difficile 
    ** The European registration, once formally granted, will
add to IMC's patent position for treatment of the disease in
Australia, New Zealand and the United States
    ** Stock down ~13% this year, as of last close 
    


 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))

Recent news on Immuron

See all news